Phenylephrine + Chlorpheniramine + Boric Acid + HydroxypropylmethylcelluloseThird Party Manufacturing in India

Phenylephrine + Chlorpheniramine + Boric Acid + Hydroxypropylmethylcellulose works by addressing vascular swelling, allergic pathways, ocular pH stabilization, and corneal lubrication simultaneously. Phenylephrine stimulates alpha-1 receptors to constrict dilated conjunctival capillaries, instantly reducing redness. Chlorpheniramine Maleate blocks histamine H1 receptors, stopping allergic symptoms like itching and watering. Boric Acid acts as a mild antibacterial buffer to regulate formulation acidity and comfort the ocular surface. Hydroxypropylmethylcellulose serves as a viscoelastic artificial lubricant that coats the cornea, extending the contact time of the active ingredients while relieving dry eye sensations. Unlike monotherapy drops, it treats multiple irritant vectors concurrently. It is highly effective and well-tolerated.

Therapeutic Uses

• Allergic Conjunctivitis: Relieves itching, burning, redness, and watery discharge caused by environmental allergens.
• Ocular Decongestion: Reduces conjunctival hyperemic states secondary to environmental dust, smoke, or wind.
• Dry Eye Symptom Relief: Soothes localized irritation and provides synthetic lubrication for compromised tear films.

Why Manufacturers Choose Phenylephrine + Chlorpheniramine + Boric Acid + Hydroxypropylmethylcellulose

This multi-action OTC formulation commands high retail turnover across the Indian domestic market due to widespread air pollution and seasonal allergies. Our partner facilities manage strict aseptic fluid operations that guarantee long-term stability and absolute sterile integrity during manufacturing under certified WHO-GMP conditions. Investing in Phenylephrine + Chlorpheniramine + Boric Acid + Hydroxypropylmethylcellulose third party manufacturing in India delivers an all-in-one product that enhances consumer compliance and therapeutic outcomes.